28035718|t|THSD7A expression in human cancer
28035718|a|We recently described a case of a Thrombospondin Type-1 Domain containing 7A (THSD7A) associated membranous nephropathy in a female patient who was synchronously suffering from a THSD7A - positive malignancy. We here investigated the role of THSD7A as a new potential tumor antigen by evaluating over 20 000 tissue spots in more than 70 different tumor entities by immunohistochemistry using tissue microarrays. THSD7A expression was highly variable in different neoplasias with differing staining patterns. Both gain and loss of THSD7A expression compared to expression status in non-tumor tissue were linked to tumor-specific markers in the different tumor entities and were of prognostic value. The potential role of THSD7A in tumor development and therapy needs further investigation.
28035718	0	6	THSD7A	T103	UMLS:C2745341
28035718	7	17	expression	T038	UMLS:C1171362
28035718	21	26	human	T204	UMLS:C0086418
28035718	27	33	cancer	T038	UMLS:C0006826
28035718	68	110	Thrombospondin Type-1 Domain containing 7A	T103	UMLS:C2745341
28035718	112	118	THSD7A	T103	UMLS:C2745341
28035718	131	153	membranous nephropathy	T038	UMLS:C4054536
28035718	196	205	suffering	T033	UMLS:C0751408
28035718	213	219	THSD7A	T103	UMLS:C2745341
28035718	222	230	positive	T033	UMLS:C1514241
28035718	276	282	THSD7A	T103	UMLS:C2745341
28035718	302	315	tumor antigen	T103	UMLS:C0041361
28035718	342	354	tissue spots	T017	UMLS:C2316370
28035718	381	395	tumor entities	T033	UMLS:C1276705
28035718	399	419	immunohistochemistry	T058	UMLS:C0021044
28035718	446	452	THSD7A	T103	UMLS:C2745341
28035718	453	463	expression	T038	UMLS:C1171362
28035718	487	507	different neoplasias	T038	UMLS:C0027651
28035718	523	540	staining patterns	T082	UMLS:C0449778
28035718	547	560	gain and loss	T033	UMLS:C0243095
28035718	564	570	THSD7A	T103	UMLS:C2745341
28035718	571	581	expression	T038	UMLS:C1171362
28035718	594	611	expression status	T038	UMLS:C1171362
28035718	615	631	non-tumor tissue	T017	UMLS:C0040300
28035718	647	669	tumor-specific markers	T103	UMLS:C0041365
28035718	687	701	tumor entities	T033	UMLS:C1276705
28035718	754	760	THSD7A	T103	UMLS:C2745341
28035718	764	781	tumor development	T033	UMLS:C1850355
28035718	786	793	therapy	T058	UMLS:C4087167